Since last year's New Hampshire Hospital shooting, some lawmakers have tried to pass legislation they say could have prevented the gunman from buying the weapon he used that day.

The state could approve another party to take over the facility's finances and operations temporarily, according to health ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

In the push to "return to normal" after the pandemic, more than 140,000 Nebraskans were pushed out of their Medicaid coverage ...

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotech ...

With the Salvation Army, you can help in numerous ways. They are seeking volunteers for teaching assistants; after-school ...

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a ...

Spurred by advances in energy-harvesting materials, a new generation of advanced implantable biomedical devices is emerging ...

Ocugen ( OCGN -6.48%) Q3 2024 Earnings Call Nov 08, 2024, 8:30 a.m. ET Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator instructions] I will now ...

Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...

There is an opportunity for GenAI to help bring better and safer drugs to market faster and more cost-efficiently, ...

Topline results from Phase 2 portion of the investigator-sponsored study of FG-3246, a first-in-class antibody-drug conjugate (ADC) targeting CD46, in combination with enzalutamide in patients with me ...